Accenture to acquire Dragos, runZero, NetRise for $4.175B

2 min read     Updated on 18 Jun 2026, 04:27 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Accenture is acquiring a majority stake in Dragos and 100% of runZero and NetRise for $4.175 billion to enhance its OT cybersecurity capabilities. The combined entities generate $208 million in annual recurring revenue. The deals are expected to close in August or September 2026.

powered bylight_fuzz_icon
43325308

*this image is generated using AI for illustrative purposes only.

Accenture has agreed to acquire a majority stake in Dragos and 100% of runZero and NetRise for a combined enterprise value of approximately $4.175 billion to strengthen its operational technology (OT) cybersecurity offerings. The acquisitions will combine Dragos' industry-leading OT threat detection platform with runZero's asset intelligence and NetRise's device security capabilities. This unified solution aims to enhance visibility, accelerate threat detection, and secure critical infrastructure such as power grids, pipelines, and manufacturing facilities against AI-driven cyber threats and geopolitical risks.

Strategic Expansion in Cybersecurity

The transactions build on Accenture's existing $10 billion cybersecurity business, which grew from $700 million in revenue in 2016 to fiscal year 2025, representing a 35% compounded annual growth rate. By integrating these companies, Accenture will expand its position from the estimated $7 billion OT cybersecurity services market into the broader OT cybersecurity market. This market is projected to grow from an estimated $27 billion opportunity in 2026 to nearly $59 billion by 2031 at approximately 16% CAGR.

Financial and Operational Impact

Together, Dragos, runZero, and NetRise are estimated to generate approximately $208 million in annual recurring revenue as of June 2026, representing 53% year-over-year growth. While initially dilutive, the acquisitions are expected to be accretive to earnings per share and free cash flow over time. The combined entity will deliver strong gross margins and position Accenture for long-term growth in the critical infrastructure and industrial operations markets.

Transaction Details and Leadership

Accenture has entered into agreements subject to customary purchase price adjustments and regulatory approvals. The transactions are expected to close in August or September 2026. Post-acquisition, runZero and NetRise will operate under Dragos, which will continue to function as an independent business based in Hanover, Maryland. Dragos co-founder and CEO Robert M. Lee will lead the expanded entity, with HD Moore of runZero and Thomas Pace of NetRise becoming key executives.

Acquisition Overview

Company Stake Acquired Specialization Employees
Dragos Majority OT threat detection 580
runZero 100% Asset intelligence 66
NetRise 100% Device security 57

Accenture's cybersecurity practice is growing by double digits, and these acquisitions align with client demands for more proactive and integrated cybersecurity approaches. The move leverages Accenture's deep OT security expertise, unique industrial datasets, and decades of trusted relationships with critical infrastructure operators.

How will the integration of Dragos, runZero, and NetRise technologies differentiate Accenture from competitors in the rapidly evolving OT cybersecurity market?

What specific regulatory hurdles could delay the projected closing timeline of August or September 2026?

How will Accenture leverage the combined $208 million in annual recurring revenue to drive further growth in the projected $59 billion OT market by 2031?

like19
dislike

Accenture to acquire Alfahealth to boost digital health in Italy

1 min read     Updated on 17 Jun 2026, 02:00 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Accenture has agreed to acquire Alfahealth, a subsidiary of Engineering Group, to enhance its healthcare capabilities in Italy. The acquisition adds approximately 1,200 specialized professionals and a digital health platform to Accenture Italy's Health practice, focusing on modernizing clinical processes and improving patient outcomes.

powered bylight_fuzz_icon
43228454

*this image is generated using AI for illustrative purposes only.

Accenture has agreed to acquire Alfahealth, a subsidiary of Engineering Group, to strengthen its healthcare capabilities in Italy by adding a service-led digital health platform. The acquisition will enable organizations to modernize clinical processes, connect data across the care continuum, and improve patient access and outcomes. Alfahealth brings more than two decades of experience in developing technology capabilities for patient journeys, including clinical workflows and diagnostics, as well as administrative processes.

The transaction reflects Accenture's strategy to combine services, software, data, and AI-powered platforms using an integrated services and product commercial model. Alfahealth's industry positioning will be enhanced with Accenture's capabilities in data, AI, cybersecurity, and cloud. The acquisition is subject to customary closing conditions, and terms were not disclosed.

Strategic Impact

Alfahealth brings approximately 1,200 specialized professionals to Accenture Italy's Health practice. The company holds a strong position in the Italian healthcare sector, supporting relevant national programs in a regulated environment. Its technology enables providers to connect data and support integrated models of care at the scale and regulatory rigor demanded by the Italian market.

"Italy is at a pivotal moment in the transformation of its healthcare system, with growing investments in digital health, interoperability and new models of care," said Teodoro Lio, Market Unit Lead for Accenture in Italy. "Together, we will help healthcare providers and institutions accelerate innovation, improve care delivery and enable more connected, data-driven and personalized experiences for all Italians."

Key Acquisition Details

Aspect Details
Target Alfahealth (subsidiary of Engineering Group)
Professionals Added Approximately 1,200
Key Capabilities Digital health platform, clinical workflows, diagnostics
Strategic Focus Data, AI, cybersecurity, cloud integration

How will the integration of Alfahealth’s platform with Accenture’s AI capabilities specifically influence patient outcomes in the Italian market?

What are the potential regulatory hurdles Accenture might face when scaling Alfahealth’s digital health platform across other European regions?

Could this acquisition trigger a wave of consolidation among digital health providers in Italy as competitors seek to match Accenture's expanded capabilities?

like18
dislike